1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Group 4: new trials by email Literature Review of Group 4 trials Research Report on Group 4
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study) iCo-007 350 mcg, iCo-007 700 mcg, iCo-007 350 mcg and Laser - Diabetic Macular Edema | Phase 2 | Terminated | Johns Hopkins University | 185 | 2012-02-01 | 2017-08-30 |
United States (1)
Brian B. Berger, MD (1) · David Callanan, MD (1) · David M. Brown, MD (1) · Dean Eliott, MD (1) · Dennis M. Marcus, MD (1) · Diana V. Do, MD (1) · Eugene Lit, MD (1) · Goergios Papastergio, MD (1) · Gregg T. Kokame, MD (1) · Henry L. Hudson, MD (1) · Homayoun Tabandeh, MD (1) · Karl G. Csaky, MD, PhD (1) · Larry S. Halperin, MD (1) · Louis Glazer, MD (1) · Michael J. Elman, MD (1)